JOURNAL OF INVESTIGATIVE DERMATOLOGY

JOURNAL OF INVESTIGATIVE DERMATOLOGY Journal

publication venue for

TYK2/JAK1 Inhibitor PF-06700841 in Patients with Plaque Psoriasis: Phase IIa, Randomized, Double-Blind, Placebo-Controlled Trial. 140:2359-+. 2020
Cells to Surgery Quiz: July 2018.. 138:e49. 2018
Cells to Surgery Quiz: July 2019 2019
Cells to Surgery Quiz: March 2019 2019
Analysis of chatGPT's responses to questions on epidermolysis bullosa 2024
Incidence and staging of merkel cell carcinoma in black patients 2024
Merkel cell carcinoma in non-white Hispanic patients: Epidemiology and primary site 2024
Patterns of systemic treatment in psoriasis patients with a history of malignancy 2024
Psoriasis is linked to a higher incidence of major adverse cardiovascular events despite statin use 2024
Proteomic profiling of CCCA reveals unique inflammatory and metabolic protein signature 2023
Exosome therapy in hair regeneration: A literature review of the evidence, challenges, and future opportunities 2022
Profiling the gut microbiome of acne patients from different racial and ethnic backgrounds 2022
Racial/ethnic differences in biologic treatment patterns among patients in the CorEvitas Psoriasis Registry 2022
Using quantitative colorimeter measurements to assess the reliability of fitzpatrick skin typing in darker skin tones 2022
Proportions of biologic discontinuation among psoriasis patients with metabolic comorbidities 2021
Regional differences in biologic treatment patterns and achievement of outcomes within the Corrona Psoriasis Registry across the US 2020
Peripheral retinal vascular leakage in moderate to severe psoriasis: A pilot study 2019
Cutaneous inflammation in the DIAMOND (TM) mouse model of non-alcoholic fatty liver disease 2019
Cutaneous inflammation in the DIAMOND (TM) mouse model of non-alcoholic fatty liver disease 2019
The vascular inflammation in psoriasis (VIP) trial: A secondary analysis of patient reported outcomes for patients treated with adalimumab, phototherapy, or placebo 2019
The vascular inflammation in psoriasis (VIP) trial: A secondary analysis of patient reported outcomes for patients treated with adalimumab, phototherapy, or placebo 2019

International Standard Serial Number (ISSN)

0022-202X

Electronic International Standard Serial Number (EISSN)

1523-1747